White AA - Search Results

1

Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.

Rajan JP, Wineinger NE, Stevenson DD, White AA. Rajan JP, et al. Among authors: white aa. J Allergy Clin Immunol. 2015 Mar;135(3):676-81.e1. doi: 10.1016/j.jaci.2014.08.020. Epub 2014 Oct 3. J Allergy Clin Immunol. 2015. PMID: 25282015

2

Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.

Stevenson DD, Mehra PK, White AA, Gupta S, Woessner KM, Simon RA. Stevenson DD, et al. Among authors: white aa. J Allergy Clin Immunol. 2005 Oct;116(4):755-60. doi: 10.1016/j.jaci.2005.05.020. Epub 2005 Jul 21. J Allergy Clin Immunol. 2005. PMID: 16210047 Clinical Trial.

3

The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.

White AA, Stevenson DD, Simon RA. White AA, et al. Ann Allergy Asthma Immunol. 2005 Oct;95(4):330-5. doi: 10.1016/S1081-1206(10)61150-7. Ann Allergy Asthma Immunol. 2005. PMID: 16279562

4

A 55-year-old woman with muscle pain and eosinophilia.

White AA, Russack V, Woessner K. White AA, et al. Allergy Asthma Proc. 2005 Nov-Dec;26(6):489-92. Allergy Asthma Proc. 2005. PMID: 16541976

5

Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease.

White A, Bigby T, Stevenson D. White A, et al. Ann Allergy Asthma Immunol. 2006 Aug;97(2):190-5. doi: 10.1016/S1081-1206(10)60012-9. Ann Allergy Asthma Immunol. 2006. PMID: 16937750 Clinical Trial.

6

Failure to maintain an aspirin-desensitized state in a patient with aspirin-exacerbated respiratory disease.

White AA, Hope AP, Stevenson DD. White AA, et al. Ann Allergy Asthma Immunol. 2006 Oct;97(4):446-8. doi: 10.1016/S1081-1206(10)60932-5. Ann Allergy Asthma Immunol. 2006. PMID: 17069096

7

Effect of leukotriene modifier drugs on the safety of oral aspirin challenges.

White A, Ludington E, Mehra P, Stevenson DD, Simon RA. White A, et al. Ann Allergy Asthma Immunol. 2006 Nov;97(5):688-93. doi: 10.1016/S1081-1206(10)61101-5. Ann Allergy Asthma Immunol. 2006. PMID: 17165280 Clinical Trial.

8

Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease.

Lee RU, White AA, Ding D, Dursun AB, Woessner KM, Simon RA, Stevenson DD. Lee RU, et al. Among authors: white aa. Ann Allergy Asthma Immunol. 2010 Aug;105(2):130-5. doi: 10.1016/j.anai.2010.05.020. Epub 2010 Jul 1. Ann Allergy Asthma Immunol. 2010. PMID: 20674823

9

Does suppression of IL-4 synthesis by aspirin explain the therapeutic benefit of aspirin desensitization treatment?

White AA, Stevenson DD. White AA, et al. J Allergy Clin Immunol. 2010 Oct;126(4):745-6. doi: 10.1016/j.jaci.2010.08.037. J Allergy Clin Immunol. 2010. PMID: 20920763 No abstract available.

10

Aspirin-exacerbated respiratory disease: burden of disease.

Chang JE, White A, Simon RA, Stevenson DD. Chang JE, et al. Allergy Asthma Proc. 2012 Mar-Apr;33(2):117-21. doi: 10.2500/aap.2012.33.3541. Allergy Asthma Proc. 2012. PMID: 22525387 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results